A Brain-Computer Interface (BCI) is designed for human-computer interactions without body movement. To improve the expression of input features closely related to a given BCI task, we propose a convolution network called GANet to analyze Event-Related Potential (ERP) in the BCI task. This model introduces the parallel convolution to extract multi-scale features in electroencephalogram (EEG) data. In addition, a Graph-based Attention (GA) mechanism is used to model interdependencies among different EEG channels. Experiments are conducted on a public dataset of 15 subjects in the specific-subject and cross-subject scenarios. The results indicate that the GANet achieves state-of-the-art performance with an accuracy of 99.75% in the specific-subject scenario and an accuracy of 81.37% in the cross-subject scenario. Different structures are discussed to analyze the contributions of the parallel convolution in feature extraction and the GA module in feature expression. GANet shows satisfied performance and good generalization in the BCI task. Our codes are publicly available at https://github.com/Debbie-85/GANet.

Detecting and treating older adults who fall in an environment without others is essential. Millimeter-wave radar sensors do not have the disadvantage of invading user privacy like cameras, nor do they require users to wear them in real-time like wearable devices. Actual samples of older adults fall are difficult to collect, and it is unethical to require older adults to fall repeatedly to collect data. In addition, different body types and action patterns will inevitably reduce the model’s performance when new users use the model. In this paper, we constructed a fall detection model based on anomaly detection. The model is trained only using non-fall samples and detects falls as abnormal actions. The proposed model uses a domain generalization architecture based on domain feature alignment to extract domain-invariant features of the model, thereby improving the model’s generalization ability. In addition, we introduced the idea of denoising learning into the feature extractor and feature predictor to improve the model’s anti-interference ability. We conducted sufficient experiments to explore the effectiveness of the proposed method. When tested with new domain data, the proposed model has a true positive rate of 96.12%, a false positive rate of 0.97%, and an area under the receiver operating characteristic of 0.9979.

Multi-label arrhythmias classification is of great significance to the diagnosis of cardiovascular disease, and it is a challenging task as it requires identifying the label subset most related to each instance. In this paper, by integrating a deep residual neural network and auto-encoder, we propose an advanced deep neural network (DNN) framework with unified feature-aware and label embedding to perform multi-label arrhythmias classification involving 30 types of arrhythmias. Firstly, a deep residual neural network is built to extract the complex pathological features from varying-dimensional electrocardiograms (ECGs). Secondly, the mean square error loss is adopted to learn a latent space associating the deep pathological features and the corresponding label data, and then to achieve unified feature-label embedding. Thirdly, the label-correlation aware loss is introduced to optimize the auto-encoder architecture, which enables our model to exploit label-correlation for improved multi-label prediction. Our proposed DNN model can allow end-to-end training and prediction, which can perform feature-aware, label embedding, and label-correlation aware prediction in a unified framework. Finally, our proposed model is evaluated on the currently largest public dataset worldwide, and achieves the challenge metric scores of 0.492, 0.495, and 0.490 on the 12-lead, 3-lead, and all-lead version ECGs, respectively. The performance of our approach outperforms other current state-of-the-art methods in the leave-one-dataset-out cross-validation setting, which demonstrates that our approach has great competitiveness in identifying a wider range of multi-label arrhythmias.

Accurate and portable Blood Pressure (BP) monitoring is vital for managing cardiovascular diseases. However, existing wearable continuous BP monitoring technologies are often inaccurate and rely on external calibration, limiting their practical application in continuous BP monitoring. To address this challenge, we have developed a Wearable continuous non-invasive BP Monitor (WeBPM) equipped with a finger cuff sensor, capable of monitoring BP continuously and accurately within medical-grade precision. WeBPM integrates advanced finger oscillographic BP measurement technology to provide reliable self-calibration functionality. Moreover, Pulsatile Cycle Volume Adjustment Method (PCVAM) we proposed for the closed-loop phase can continuously track changes in vasomotor tone under a controlled frequency based on pulsatile cycles, thereby enabling continuous BP measurement. In comparative experiments with the Nexfin monitor, WeBPM demonstrates excellent performance in induced dynamic BP experiments, with measurement errors of (–1.4 $\pm$ 6.24) mmHg for Systolic BP (SBP) and (–0.82 $\pm$ 4.83) mmHg for Diastolic BP (DBP). Additionally, compared to clinical invasive reference measurements, WeBPM’s SBP and DBP measurement errors are (–1.74 $\pm$ 4.9) mmHg and (0.37 $\pm$ 3.28) mmHg, respectively, further proving its outstanding performance. These results highlight WeBPM’s potential in personalized health management and remote monitoring, offering a new solution for continuous non-invasive BP monitoring.